← SynDRA
FLIBANSERIN
SynDRA canonical compound SYN0007446 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | DRD4 | HTR1A | HTR2A |
|---|
| Mechanism of action | serotonin receptor agonist |
|---|
| Indication | hypoactive sexual desire disorder |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- HTR1A
- HTR2A
- DRD4
- DRD2
- DRD3
- HTR2B
- HTR2C
- HTR5A
- Htr1a
Mechanisms of action (all sources)
- HTR1A AGONIST
- HTR2A ANTAGONIST
- serotonin receptor agonist
- HTR2A MODULATOR
- HTR1A MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADRA1A
- DRD1
- OPRM1
- ABCB11
- KDR
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PGR
- PDE4A
- PDE3A
- MAOA
- HRH3
- KCNH2
- ACHE
- HDAC6
- F2
- ESR1
- CHRM2
- CHRM1
- AR
- ADRA2A
- ADORA3
- TBXA2R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT1A
- 5HT2A
- CP2D6
- CP3A7
- KSYK
- SYK
Drug classes
- P-Glycoprotein Inhibitors
ATC classes
- G02C · OTHER GYNECOLOGICALS
Cross-references
Synonyms
- ADDYI
- Addyi
- addyi
- ectris
- BIMT 17
- Flibanserine
- Flibanserina
- Ectris
- BIMT-17
- BIMT-17-BS
- Flibanserin [USAN]
- Bimt-17
- Bimt 17
- Girosa
- flibanserina
- Female Viagra (Street Name)
- Female Viagra [Street Name]
- CHEBI:90865
- flibanserinum
- RefChem:57689
- G02CX02
- DTXCID001781318
- MFCD00918402
- Filbanserin.
- Flibanserin [USAN:INN]
- UNII-37JK4STR6Z
- Flibanserin?
- Addyi (TN)
- Flibanserin (Standard)
- FLIBANSERIN [MI]
- FLIBANSERIN [INN]
- Flibanserin (USAN/INN)
- FLIBANSERIN [MART.]
- FLIBANSERIN [WHO-DD]
- Girosa (proposed trade name)
- SCHEMBL247579
- GTPL8182
- orb1302975
Reported adverse events
- Accident
- Anxiety
- Appendicitis
- Constipation
- Dizziness
- Dry mouth
- Fatigue
- Gastrointestinal disorder
- Hypotension
- Injury
- Insomnia
- Nausea
Look up FLIBANSERIN in the interactive SynDRA portal →